Pharmaceutical

Inovio’s INO-3107 receives orphan drug status from EC

INO-3107 also received orphan drug designation from the US Food and Drug Adminis...

Y-mAbs’ Danyelza injection receives marketing approval ...

Danyelza will be given three times in a week to patients and the dosage will be ...

Forge Biologics joins BGTC for new AAV gene therapies d...

BGTC creates a reusable standardised method, which reduces upfront costs and dev...

Supplies of Novo Nordisk’s Wegovy starter doses to be l...

Key opinion leaders (KOLs) interviewed by GlobalData have highlighted that despi...

FDA approves breakthrough pneumonia therapy

The FDA approved Xacduro, developed by Entasis which is now a part of Innoviva, ...

Untangling the Complexities of Cell and Gene Therapy Cl...

By Luisa Sterkel & Joana Loureiro, Tenthpin Consultants The promise and potentia...

Nona Biosciences and ModeX Therapeutics partner for ant...

ModeX will gain access to Nona Bioscience’s fully human Harbour Mice platforms.

CohBar and Morphogenesis in merger for immuno-oncology ...

The combined company will advance Morphogenesis’ personalised cancer vaccines an...

US government plans proposal to push down Medicaid drug...

The Department of Health and Human Services details new plans to survey drug cos...

FDA greenlights new long-term treatment option for opio...

Braeburn’s extended-release injection, Brixadi, joins a growing list of approval...

STAT+: Congress highlighted a chemo drug’s price to bla...

The House Oversight Committee hearing is the latest in a wave of bipartisan cong...

A deep dive on generative AI in health care, Pear sold ...

In the latest edition of STAT's Health Tech newsletter: A deep dive on generativ...

HIV rates decline in U.S., data show, but disparities p...

Experts acknowledged the good news mixed in with disappointments in the latest r...

STAT+: Learning to treat long COVID could help those st...

People who suffer from chronic fatigue syndrome say their symptoms have often be...

STAT+: Pharmalittle: Pfizer and Novo disclose upbeat da...

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to ...

FDA budget battles, prisons’ sobering Covid response & ...

BIO is taking steps toward finding its next leader after a messy separation from...